Ak4aq Pharmaceutical Private Limited

Ak4aq Pharmaceutical Private Limited - pharma in Delhi, India. Directors, charges & compliance details.
CIN U24290DL2022PTC406794 Incorporated 13 November 2022 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹79,684
▲ 145% YoY
Net profit · FY 2025
₹5,052
Net margin 6.3%
EBITDA · FY 2025
₹5,459
EBITDA margin 6.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Ak4aq Pharmaceutical Private Limited

Data last updated:

Ak4aq Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 November 2022.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2022PTC406794.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Abdul Qadir and Abdul Hamid.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 1352 Ground Floor J Colony Tigri New, Delhi, India – 110080.

As per the financials filed for FY 2025, the company reported a revenue of ₹79,684, a growth of 145% compared to the previous year. For the same year it recorded a net profit of ₹5,052 (net margin 6.3%) and EBITDA of ₹5,459 (EBITDA margin 6.9%).

Ak4aq Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0026250). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24290DL2022PTC406794
Registration Number 406794
Incorporation Date 13 November 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0026250

Recognitions & Rankings of Ak4aq Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-DL-03-0026250

Contact details

Ak4aq Pharmaceutical Private Limited's registered office is in Delhi, Delhi.

  • Registered Address
    C – 1352 Ground Floor J Colony Tigri New, Delhi, India – 110080
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Ak4aq Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ak4aq Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Ak4aq Pharmaceutical Private Limited, buy the company report.

Financials of Ak4aq Pharmaceutical Private Limited

FY 2025 filings available

Ak4aq Pharmaceutical Private Limited reported revenue of ₹79,684 (up 145% YoY) for FY 2025.

Revenue · FY 2025
₹79,684 ▲ 145%
Net profit · FY 2025
₹5,052 margin 6.3%
EBITDA · FY 2025
₹5,459 margin 6.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 145%
EBITDA CAGR growth
1 year
▲ 514%

Revenue rose 145% in the latest year. EBITDA rose 514% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5,459
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5,052
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin6.9%
Net Profit Margin6.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ak4aq Pharmaceutical Private Limited, buy the company report.

Board of directors of Ak4aq Pharmaceutical Private Limited

Ak4aq Pharmaceutical has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Abdul QadirDirector13 Nov 20224 Years 0 MonthsCurrent
Abdul HamidDirector13 Nov 20224 Years 0 MonthsCurrent
Aqsa KhanDirector13 Nov 20224 Years 0 MonthsCurrent

Peer comparison

Ak4aq Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Espritway Services Private Limited₹82,001 (FY 2025)13.0%Saran, Bihar, India
Bespharma Private Limited₹81,200 (FY 2024)Bangalore, Karnataka, India
Manobala Aushads Private Limited₹80,888 (FY 2023)-63.0%Mandya, Karnataka, India
Blue Jade Texink Private Limited₹80,000 (FY 2025)-96.0%Amritsar, Punjab, India
Nivija Private Limited₹79,980 (FY 2022)Noida, Uttar Pradesh, India
Ak4aq Pharmaceutical Private Limitedthis company₹79,684 (FY 2025)₹5,0526.3%145.0%Delhi, India
Vishyam Industries Private Limited₹79,593 (FY 2025)-97.0%Nanded, Maharashtra, India
Kea Biotech Private Limited₹79,445 (FY 2025)-49.0%Hyderabad, Telangana, India
Adiyal International Trade & Consultancy Private Limited₹79,400 (FY 2025)-83.0%Delhi, India
Mickle Felix Pharmaceuticals Private Limited₹79,195 (FY 2025)-73.0%Delhi, India
Uppeel Consumer Care Private Limited₹78,750 (FY 2024)Thane, Maharashtra, India

To see the full peer comparison of Ak4aq Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ak4aq Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Ak4aq Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Ak4aq Pharmaceutical Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Abdul Hamid was appointed as Director on 13 Nov 2022.

AGM
Ak4Aq Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ak4Aq Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Abdul Hamid was appointed as Director.
Appointed
Abdul Qadir was appointed as Director.
Appointed
Aqsa Khan was appointed as Director.
Incorporation
13 Nov 2022
Ak4Aq Pharmaceutical Private Limited was registered on 13 Nov 2022 with Roc Delhi I & aged 4 years 3 days as per MCA records.

Frequently asked questions

Ak4aq Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 November 2022 (4+ years old) and is registered under CIN U24290DL2022PTC406794.

Ak4aq Pharmaceutical has 3 current directors:

The latest financial statements of Ak4aq Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Ak4aq Pharmaceutical is U24290DL2022PTC406794. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ak4aq Pharmaceutical was incorporated on 13 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Ak4aq Pharmaceutical by revenue are Espritway Services Private Limited, Bespharma Private Limited, Manobala Aushads Private Limited, Blue Jade Texink Private Limited, Nivija Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Abdul Hamid was appointed as Director on 13 Nov 2022. Abdul Qadir was appointed as Director on 13 Nov 2022. Aqsa Khan was appointed as Director on 13 Nov 2022.

Yes, Ak4aq Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0026250).

The registered office of Ak4aq Pharmaceutical is at C – 1352 Ground Floor J Colony Tigri New, Delhi, India – 110080.

Ak4aq Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Ak4aq Pharmaceutical is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.